Crohn’s Disease Therapeutics Market, valued at USD 7.47 billion in 2023, is set to grow at a CAGR of 5.9% from 2024 to 2030, reaching approximately USD 11.16 billion. This growth is driven by the rising prevalence of Crohn's disease, advancements in biosimilars, and increased access to affordable biologics. Enhanced R&D efforts in developing innovative treatments, including...